A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duple
A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.
대표청구항▼
1. A method of delaying, inhibiting or otherwise reducing the expression of a target gene in an animal cell, the method comprising introducing into said animal cell an expression construct, wherein said expression construct comprises an inverted-duplication of a segment of said target gene wherein s
1. A method of delaying, inhibiting or otherwise reducing the expression of a target gene in an animal cell, the method comprising introducing into said animal cell an expression construct, wherein said expression construct comprises an inverted-duplication of a segment of said target gene wherein said inverted-duplication of the target gene segment comprises a nucleotide sequence substantially identical to at least a portion of the target gene and the complement of said portion of the target gene, and wherein a single promoter is used to drive expression of said inverted-duplication of the target gene segment, and wherein said inverted-duplication contains at least one copy of said portion of the target gene segment in the sense orientation. 2. The method according to claim 1, wherein said inverted-duplication contains at least one copy of said portion of the target gene segment in the antisense orientation. 3. A method of delaying, inhibiting or otherwise reducing the expression of a target gene in an animal cell, comprising expressing in said animal cell an expression construct, wherein said expression construct comprises a first and a second copy of a segment of the target gene, wherein each copy of said target gene segment is identical and separately placed under the control of a first and a second promoter, respectively, which are operable in said cell, and wherein said target gene segment comprises a nucleotide sequence which is substantially identical to at least a portion of the target gene, and wherein the first copy of said target gene segment is placed operably in the sense orientation under the control of the first promoter and wherein the second copy of said target gene segment is placed operably in the antisense orientation under the control of the second promoter. 4. The method according to any one of claims 1, 2 or 3, wherein said target gene segment is at least 25 nucleotides long. 5. The method according to claim 1, wherein said target gene segment comprises a nucleotide sequence that is identical to said portion of the target gene. 6. The method of claim 1 or 3, wherein the animal cell is not a mammalian cell. 7. A method of delaying, inhibiting or otherwise reducing the expression of a target gene in an animal cell, the method comprising introducing into said animal cell an expression construct, wherein said expression construct comprises an inverted-duplication of a segment of the target gene wherein said inverted-duplication of the target gene segment comprises a nucleotide sequence substantially identical to a nucleotide sequence of 25-50 consecutive nucleic acids in length of the target gene segment and the complement of said 25-50 consecutive nucleic acids of the target gene segment, and wherein a single promoter is used to drive expression of said inverted-duplication of the target gene segment, and wherein said inverted-duplication contains at least one copy of said 25-50 consecutive nucleic acids of the target gene segment in the sense orientation. 8. The method according to claim 7, wherein said inverted-duplication contains at least one copy of said target gene segment in the antisense orientation. 9. A method of delaying, inhibiting or otherwise reducing the expression of a target gene in an animal cell, comprising expressing in said animal cell an expression construct, wherein said expression construct comprises a first and a second identical copy of a segment of the target gene that is substantially identical to 25-50 consecutive nucleic acids of the target gene segment, wherein each copy of said segment of the target gene is separately placed under the control of a first and a second promoter, respectively, which are operable in said cell, and wherein the first copy of said target gene segment is placed operably in the sense orientation under the control of the first promoter and the second copy of said target gene segment is placed operably in the antisense orientation under the control of the second promoter. 10. The method according to claim 7 or claim 9, wherein said target gene segment comprises a nucleotide sequence that is identical to said portion of the target gene. 11. The method of claim 1, wherein a spacer nucleotide sequence is located between the nucleotide sequence substantially identical to at least a portion of the target gene and the complement of said portion of the target gene. 12. The method of claim 7, wherein a spacer nucleotide sequence is located between the nucleotide sequence substantially identical to the nucleotide sequence of 25-50 consecutive nucleic acids in length of the target gene segment and the complement of said 25-50 consecutive nucleic acids of the target gene segment. 13. The method of claim 1, wherein the target gene is a cellular gene, an endogenous gene, a viral gene or a transgene. 14. The method of claim 1 or claim 7, wherein the animal cell is a mammalian cell.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (70)
Nugiel David A. ; Carini David J. ; Di Meo Susan V. ; Vidwans Anup P. ; Yue Eddy W., Acylsemicarbazides and their uses.
Shewmaker Christine K. (Davis CA) Kridl Jean C. (Davis CA) Hiatt William R. (Davis CA) Knauf Vic (Davis CA), Anti-sense regulation of gene expression in plant cells.
Grierson Donald (Loughbrough GB2) Hamilton Andrew J. (Nottingham GB2) Lycett Grantley W. (Loughbrough GB2), Antisense constructs derived from pTOM13 plants and plant cells with reduced ethylene evolution.
Shewmaker Christine K. (Woodland CA) Kridl Jean C. (Davis CA) Hiatt William R. (Davis CA) Knauf Vic (Winters CA), Antisense regulation of gene expression in plant/cells.
Noren Christopher J. (Rockport MA) Evans Paul D. (Camp Verde AZ), Bidirectional in vitro transcription vectors utilizing a single RNA polymerase for both directions.
Grierson Donald (Loughbrough GB2) Hamilton Andrew J. (Nottingham GB2) Lycett Grantley W. (Loughbrough GB2), DNA constructs containing the gene for ACC Oxidase, cells and plants derived therefrom.
Dattagupta Nanibhushan ; Sridhar C. Nagaraja ; Kacian Daniel L., Enhancement of oligonucleotide inhibition of protein production, cell proliferation and / or multiplication of infectio.
Jonathan Edward Lightner ; John Joseph Okuley ; William Hitz ; Anthony John Kinney ; Luis Perez-Grau ; Narendra S. Yadav, Genes for microsomal delta-12 fatty acid desaturases and hydroxylases from plants.
Noonberg Sarah B. (Berkeley CA) Hunt C. Anthony (San Francisco CA), In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides deriv.
Skurkovich Simon V. (261 Congressional La. ; #709 Rockville MD 20852), Methods for the treatment of pathological conditions by removing interferon from the organism.
Ts\o Paul O. P. (2117 Folkstone Rd. Lutherville MD 21093) Miller Paul S. (225 Hopkins Rd. Baltimore MD 21212), Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof.
Miller Paul S. (Baltimore MD) Ts\O Paul O. P. (Lutherville MD), Process for selectively controlling unwanted expression or function of foreign nucleic acids in animal or mammalian cell.
Jendrisak Jerome J. (Madison WI) Lewis Martin K. (Madison WI) Fiandt Michael J. (Cambridge WI), Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.